XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Original Additional paid-in capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Series A Preferred Stock [Member]
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Total
Balance, Beginning at Sep. 30, 2018 $ 69,323 $ 2,065,018 $ 971 $ (5,998,535) $ 2,990,535 $ 510 $ 1,000 $ 447 $ (870,731)
Balance, Beginning (in shares) at Sep. 30, 2018 69,323,021       5,000,000 509,988 1,000,000 446,975  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued for conversion of convertible note payable and accrued interest $ 97,645 341,118             438,763
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 97,644,262                
Common stock sold to officer for cash $ 3,500 64,750             68,250
Common stock sold to officer for cash (in shares) 3,500,000                
Beneficial conversion discount on convertible notes payable   354,326             354,326
Cancellation of Series F   60           $ (60)  
Cancellation of Series F (in shares)           (60,000)   (60,000)  
Dividend on Preferred A   (1,600,000)     $ 1,600,000       1,600,000
Dividend on Preferred A (in shares)         800,000        
Other comprehensive loss     (971)           (971)
Net loss       (675,072)         (675,072)
Balance, End at Sep. 30, 2019 $ 170,468 1,225,272 (6,673,607) $ 4,590,535 $ 510 $ 1,000 $ 387 (685,435)
Balance, End (in shares) at Sep. 30, 2019 170,467,283       5,800,000 509,988 1,000,000 386,975  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued for conversion of convertible note payable and accrued interest $ 250,749 (18,609)             232,140
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 250,751,059                
Stock-based compensation $ 10,000 25,500             35,500
Stock-based compensation (in shares) 10,000,000                
Common stock sold to officer for cash $ 5,000 (4,500)             500
Common stock sold to officer for cash (in shares) 5,000,000                
Beneficial conversion discount on convertible notes payable   187,000             187,000
Return of Series A preferred shares for legal settlement   4,703,339     $ (4,590,535)       112,804
Return of Series A preferred shares for legal settlement (in shares)         (5,800,000)        
Dividend on Preferred A                
Net loss       (541,731)         (541,731)
Balance, End at Sep. 30, 2020 $ 436,217 $ 6,118,002 $ (7,215,338) $ 510 $ 1,000 $ 387 $ (659,222)
Balance, End (in shares) at Sep. 30, 2020 436,218,342       509,988 1,000,000 386,975